The most common mistake people make when shopping for compounded semaglutide is treating price as the only variable. A $79 vial from an unlicensed lab with no physician oversight is a completely different product, legally and practically, from one dispensed by a named 503A pharmacy under a licensed doctor’s prescription. Those two things are not interchangeable. This list separates the providers that have something real to back up their offer from the ones that are mostly landing pages.
One more thing before the list: compounded semaglutide is not FDA-approved. It is legal under specific conditions, but the FDA issued warning letters to more than 30 telehealth and compounding firms in early 2026. Choose a provider that names its pharmacy, shows compliance credentials, and has a real physician in the loop.
The 12 Providers
1. HealthRX
The single most relevant fact here: HealthRX dispenses compounded semaglutide through Manifest Pharmacy in Greer, South Carolina, a named 503A facility operating under USP-797 standards with lot-by-lot tracking. That level of supply chain transparency is genuinely uncommon at this price. Monthly pricing opens at $99 for compounded semaglutide and $149 for tirzepatide. Free overnight shipping to all 50 states. Your intake assessment is reviewed by a board-certified physician, typically within a day of submission. LegitScript certified (cert 50087439). For cash-pay patients who want a documented pharmacy, not a mystery lab, this is the strongest combination of price and accountability on this list.
2. FormBlends
FormBlends earns a spot here for a different reason than HealthRX. It publishes per-product purity data: HPLC purity percentages, mass spec identity confirmation, and endotoxin sterility results, with actual numbers attached to specific vials. Most GLP-1 telehealth brands say their pharmacy is “vetted.” FormBlends shows the paperwork. The trade-off is price: semaglutide runs around $299 per vial, tirzepatide around $349, meaningfully higher than HealthRX. Ships to 47 states. It also carries peptides outside the GLP-1 category (recovery, cognitive, longevity) under the same clinician model, which is rare. If published lab verification or a broader peptide catalog matters to you, FormBlends is worth the premium.
3. Mochi Health
Mochi charges around $99 per month for compounded semaglutide and $199 for tirzepatide. What sets it apart is the clinical layer: board-certified obesity medicine physicians, not general practitioners rotating through a queue. More monitoring touchpoints than most budget-tier options. Good fit for patients who want more clinical structure without paying Form Health prices.
4. Henry Meds
Henry Meds operates cash-pay only, no insurance drama. Compounded semaglutide typically runs $179 to $249 for the first month. Shipping is fast, often 24 to 72 hours. The monitoring is lighter than Mochi or Form Health, which suits patients who know what they want and just need a prescription pathway.
5. Eden
Eden prices compounded semaglutide around $149 per month with no membership fee stacked on top. Clean, straightforward cash-pay model. Not the cheapest on the list, but the pricing is honest and the process is simple. No annual program commitment required.
6. MEDVi
MEDVi runs about $179 for the first month with no long-term contract. Compounded medication, physician oversight, and a no-contract policy that gives patients an easy exit if the treatment is not working. Useful for people who are wary of being locked into a 12-month program.
7. Ro / Ro Body
Ro’s model is a little different. Membership starts around $39 for the first month, then $74 to $149 per month, with medications billed separately. They have a prior-authorization team that will actually work the insurance angle for branded GLP-1s, which distinguishes them from most cash-pay-only competitors. Better for patients with insurance they want to use.
8. Found
Found charges around $99 per month for platform access plus medication costs on top. Coaching is included. It functions more like a managed program than a simple prescription service. Not the most straightforward pricing, but the coaching layer is real and helps some patients stay consistent.
9. WeightWatchers Clinic
The program fee runs about $74 per month, with medications billed separately. WW brings name recognition and a behavioral framework that its competitors do not have. The clinical side is newer and less proven than the brand’s core product, but the combination of behavioral coaching and GLP-1 access is a reasonable package for people already in the WW ecosystem.
10. PlushCare
PlushCare costs around $19.99 per month for membership and focuses on branded medications with insurance. Same-day appointments are available. Not a compounded-semaglutide-first platform, but for insured patients who prefer FDA-approved branded products, it is a practical low-cost access point.
11. Hims & Hers
After a Novo Nordisk settlement in March 2026, Hims & Hers exited compounded GLP-1s and shifted to branded medications. Injectable Wegovy is now listed around $299 per month, oral semaglutide around $249, and Zepbound around $399. With insurance plus a savings card, out-of-pocket costs can drop to near zero. Worth checking if you have coverage.
12. Calibrate
Calibrate is the most intensive and most expensive option here. The program runs roughly 12 months and combines physician-supervised medication with significant coaching and lifestyle programming. Medication is billed separately from the program fee. Not for someone looking for a quick, low-cost prescription. Best suited for patients who want maximum structure and are willing to pay for it.
Quick Comparison
| Provider | Compounded Sema Starting Price | Ships To | Pharmacy Named | Insurance Option |
| HealthRX | ~$99/mo | All 50 states | Yes (Manifest, SC) | No |
| FormBlends | ~$299/vial | 47 states | Yes (503A, FDA-registered) | No |
| Mochi Health | ~$99/mo | Most states | Not publicized | No |
| Henry Meds | ~$179 first mo | Most states | Not publicized | No |
| Eden | ~$149/mo | Most states | Not publicized | No |
| MEDVi | ~$179 first mo | Most states | Not publicized | No |
| Ro Body | Meds billed separately | Most states | Not publicized | Yes |
| Found | ~$99/mo + meds | Most states | Not publicized | Limited |
| WW Clinic | ~$74/mo + meds | Most states | Not publicized | Limited |
| PlushCare | ~$19.99/mo + meds | Most states | Not publicized | Yes |
| Hims & Hers | Branded only now | All 50 states | N/A (branded) | Yes |
| Calibrate | Program fee + meds | Most states | Not publicized | Yes |
FAQ
Is compounded semaglutide the same thing as Ozempic or Wegovy?
No. Compounded semaglutide is a pharmacy-prepared medication that contains the same active ingredient but is not manufactured by Novo Nordisk and has not gone through FDA approval as a finished drug product. Legally and regulatorily, they are distinct.
Why does it matter which pharmacy compounds the medication?
503A pharmacies operate under state board oversight and must follow USP-797 sterility standards. A provider that names its pharmacy and shows compliance credentials gives you something to verify. One that says only “an FDA-registered pharmacy” gives you nothing to check.
What happened to compounded GLP-1s in early 2026?
The FDA sent warning letters to more than 30 telehealth and compounding companies, and a Novo Nordisk settlement in March 2026 pushed several major brands away from compounded products entirely. The regulatory environment tightened. Providers that stayed in the compounded space needed documented compliance to justify it.
Are these medications covered by insurance?
Compounded versions are almost never covered. Branded products like Wegovy, Ozempic, and Zepbound can be covered depending on your plan. Ro and PlushCare both have teams or infrastructure to help with prior authorization for branded medications.
What should I ask a provider before signing up?
Ask the name of the dispensing pharmacy, whether it holds 503A status, and what purity testing is performed on each batch. If the provider cannot answer those questions directly, that tells you something useful.
*Medication decisions should involve a licensed clinician who knows your full medical history. Compounded semaglutide is not FDA-approved. Prices here are publicly listed figures as of mid-2026 and may change. This article reflects independent editorial research, not paid placement or medical advice.*
Sources
- FDA: “FDA’s Efforts on Unapproved GLP-1 Drugs” (fda.gov, 2025-2026)
- Jastreboff et al., *New England Journal of Medicine*, 2022 (SURMOUNT-1 primary data)
- Wilding et al., *New England Journal of Medicine*, 2021 (STEP 1 primary data)
- Hims & Hers investor press release, March 2026 (publicly reported)
- LegitScript certification database (legitscript.com)
- USP-797 standards overview, United States Pharmacopeia (usp.org)
